Role of FGF21 in breast cancer
Part of Cancer, Skin clinical trials.
This study looks at the role of a protein called FGF21 in breast cancer. It aims to understand how FGF21 relates to the disease and could help in diagnosis or treatment. The study is for women who have been diagnosed with breast cancer and are being treated at a specific cancer institute in South Egypt.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman.
- You have been diagnosed with breast cancer.
- The diagnosis was made using clinical exams, imaging tests, and lab tests (pathology).
- You are being treated or evaluated at the South Egypt Cancer Institute.
- You have not been diagnosed with any other type of cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a type of immune cell in the blood of women with breast cancer. It may help doctors understand how the body fights cancer and could guide future treatments.
This study looks at specific molecules in the body that can change how your genes work (epigenetic mediators) in women who have just been diagnosed with breast cancer. The goal is to understand these markers better, which could help improve treatment in the future.
This study looks at a specific protein in breast cancer tissue to see if it can help doctors understand the cancer better. It involves testing tissue samples from women with breast cancer.
This study looks at a protein called GDF-15 in the blood and how it relates to side effects like weight loss during treatment with the drug T-DXd for advanced breast cancer. By joining, you help researchers learn more about managing these side effects.
This study tests a new medication called GcMAF (a type of protein therapy) for people with advanced breast cancer that has spread. It may help your immune system fight the cancer, and you might receive either the study drug or a placebo (a pill with no active medicine).
This study looks at a blood marker called IL-7 to see if it can help with breast cancer. It aims to find out if this marker might be useful for diagnosis or follow-up.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.